- Home
- ELTK vs STRO Comparison
ELTK vs STRO Comparison
Compare ELTK & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- STRO
- Stock Information
- Founded
- ELTK 1970
- STRO 2003
- Country
- ELTK Israel
- STRO United States
- Employees
- ELTK N/A
- STRO N/A
- Industry
- ELTK Electrical Products
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELTK Technology
- STRO Health Care
- Exchange
- ELTK Nasdaq
- STRO Nasdaq
- Market Cap
- ELTK 69.5M
- STRO 77.7M
- IPO Year
- ELTK 1997
- STRO 2018
- Fundamental
- Price
- ELTK $10.39
- STRO $0.76
- Analyst Decision
- ELTK
- STRO Hold
- Analyst Count
- ELTK 0
- STRO 7
- Target Price
- ELTK N/A
- STRO $3.97
- AVG Volume (30 Days)
- ELTK 39.6K
- STRO 1.4M
- Earning Date
- ELTK 08-14-2025
- STRO 08-12-2025
- Dividend Yield
- ELTK 1.87%
- STRO N/A
- EPS Growth
- ELTK N/A
- STRO N/A
- EPS
- ELTK 0.51
- STRO N/A
- Revenue
- ELTK $47,500,000.00
- STRO $66,434,000.00
- Revenue This Year
- ELTK $18.60
- STRO N/A
- Revenue Next Year
- ELTK $9.04
- STRO N/A
- P/E Ratio
- ELTK $20.01
- STRO N/A
- Revenue Growth
- ELTK 1.05
- STRO N/A
- 52 Week Low
- ELTK $7.65
- STRO $0.52
- 52 Week High
- ELTK $12.19
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- ELTK 52.74
- STRO 44.98
- Support Level
- ELTK $10.27
- STRO $0.67
- Resistance Level
- ELTK $11.69
- STRO $0.87
- Average True Range (ATR)
- ELTK 0.74
- STRO 0.08
- MACD
- ELTK -0.01
- STRO -0.01
- Stochastic Oscillator
- ELTK 52.12
- STRO 34.81
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.